Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: hepatitis c + hepatitis + need  Related to the article below (Last Update: 8/5/2008)

Vertex falls on data for Schering hepatitis drug
BusinessWeek -
BY MARLEY SEAMAN Shares of Vertex Pharmaceuticals Inc. fell Monday after Schering-Plough Corp. reported positive data from a trial of a hepatitis C drug, ...
Schering-Plough reports positive top-line results for hepatitis C ... RTT News
Vertex on the Verge of Victory Motley Fool
Vertex stock hurt by rival's news Bizjournals.com
Reuters - Market Intelligence Center
all 31 news articles »  VRTX - SGP - JNJ
Indo-American doctor's hearing in hepatitis case delayed
Hindustan Times, India -
PTI The disciplinary hearing of an Indo-American doctor, whose diagnostic centre has been accused of a Hepatitis C outbreak in Las Vegas, has been postponed ...
Desai Hearing Rescheduled For February KXNT
all 12 news articles »
Altered expression of cell cycle and apoptotic proteins in chronic ...
7thSpace Interactive (press release), NY -
A disrupted cell cycle progression of hepatocytes was reported in chronic hepatitis C virus (HCV) infection, which can contribute significantly in the ...
Warfarin may prevent liver failure in hepatitis C patients
Healthcare Republic (press release), UK -
Warfarin could be used to prevent liver failure in thousands of patients with hepatitis C, a new study suggests. UK researchers found that warfarin ...
Southern Nevada Identifies Source Cases For Hepatitis C Outbreak
eMaxHealth.com, NC -
The Southern Nevada Health District has identified two source cases related to the hepatitis C outbreak at the Endoscopy Center of Southern Nevada, ...
Liver Damage In Hepatitis C Patients Could Be Treated With ...
Science Daily (press release) - Aug 1, 2008
2, 2008) ? The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research. ...
New Treatment Therapy Helps Inhibit Hepatitis C
Science Daily (press release) - Jul 31, 2008
ScienceDaily (July 31, 2008) ? Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C. The ...
Vertex hepatitis C drug meets study goal
Forbes, NY - Aug 1, 2008
AP 08.01.08, 9:20 AM ET Vertex Pharmaceuticals Inc. said late Thursday its hepatitis C drug candidate telaprevir was both safe and prompted a response in ...
Vertex Pharmaceuticals Incorporated. Q2 2008 Earnings Call Transcript Seeking Alpha
Vertex narrows 2Q loss, but misses forecast Forbes
all 10 news articles »  VRTX
Govt to launch health insurance policy
The News - International, Pakistan -
This was stated by Parliamentary Secretary for Health Dr Mehreen Bhutto while talking to newsmen after the inauguration of the Hepatitis C Centre at the ...
Pen Injectors Becoming Dominant Force in Many Therapeutic Sectors
PharmaLive.com (press release), PA -
Patients suffering from conditions such as rheumatoid arthritis, multiple sclerosis and Hepatitis C are often able to achieve a higher quality of life using ...
Source: Google News

Classification of chronic viral hepatitis: a need for reassessment. -
PJ Scheuer - J Hepatol, 1991 - ncbi.nlm.nih.gov
J Hepatol. 1991 Nov;13(3):372-4. Classification of chronic viral hepatitis: a
need for reassessment. Scheuer PJ. Department of Histopathology ...

[CITATION] The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination … -
MJ Alter, SC Hadler, HS Margolis, WJ Alexander, PY … - JAMA: The Journal of the American Medical Association, 1990 - JAMA
... Need for alternative vaccination strategies. ... FULL TEXT. Prospective study of hepatitis
B vaccination in patients with chronic hepatitis C Wong et al. ...

Epidemiology of hepatitis C -
MJ Alter - Hepatology, 1997 - doi.wiley.com
... potential risks for HCV infection and transmission, the need based serologic
study of hepatitis C virus infection in the United States ...

… interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial -
MP Manns, JG McHutchison, SC Gordon, VK Rustgi, M … - The Lancet, 2001 - Elsevier
... Articles. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b
plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. ...

… -term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, … -
RS Garfein - American Journal of Public Health, 1996 - Am Public Health Assoc
... Test results for hepatitis C virus (HCV), hepatitis B virus (HBV ... of HCV, HBV, and
HIV infections among short-term injectors emphasizes the need to target ...

Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A … -
CS Graham, LR Baden, E Yu, JM Mrus, J Carnie, T … - Clinical Infectious Diseases, 2001 - UChicago Press
... Patients with HIV need to be evaluated for HCV infection, and we agree that HCV
should be defined as an opportunistic ... Hepatitis C: global prevalence (update). ...

Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic … -
… Zins, F Driss, B Lebkiri, F Carnot, P Berthelot, C … - Kidney Int, 1993 - nature.com
... terminal sequence of hepatitis C virus genome. Jpn J Exp Med 60:167?177, 1990; Scheuer
PJ: Classification of chronic viral hepatitis: A need for reassessment. ...

Natural history of chronic hepatitis C -
LB Seeff - Hepatology, 2002 - doi.wiley.com
... In contrast, portal hypertension, other features of liver fail- ure, the need for
liver transplantation ... The question of whether chronic hepatitis C per se has ...

Host genetic factors influence disease progression in chronic hepatitis C -
… AD Clouston, DH Crawford, C Shorthouse, DM Purdie … - Hepatology, 2000 - doi.wiley.com
... in Chronic Hepatitis C ... Progressive hepatic fibrosis and cirrhosis develops in
20% to 30% of patients with chronic hepatitis C virus (HCV). ...

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness -
L Stuyver, S De Gendt, C Van Geyt, F Zoulim, M … - Journal of General Virology, 2000 - Soc General Microbiol
... of this strain was found to be more than 11% in the Georgia area, USA, but needs
to be ... Epidemiology and prevention of chronic hepatitis B and C in North and ...

Source: Google Scholar
 

What I need to know about Hepatitis C

What is hepatitis C?

Hepatitis C is a liver disease.

Hepatitis (HEP-ah-TY-tis) makes your liver swell and stops it from working right.

You need a healthy liver. The liver does many things to keep you alive. The liver fights infections and stops bleeding. It removes drugs and other poisons from your blood. The liver also stores energy for when you need it.

What causes hepatitis C?

Hepatitis C is caused by a virus.

A virus is a germ that causes sickness. (For example, the flu is caused by a virus.) People can pass viruses to each other. The virus that causes hepatitis C is called the hepatitis C virus.

Article continues below and (thank you)

 

Image of the location of the liver in the human body.

 

How could I get hepatitis C?

Hepatitis C is spread by contact with an infected person's blood.

You could get hepatitis C by

Man offering another man a syringe.

 

You could get hepatitis C by sharing drug needles.

  • sharing drug needles
  • getting pricked with a needle that has infected blood on it (hospital workers can get hepatitis C this way)
  • having sex with an infected person, especially if you or your partner has other sexually transmitted diseases
  • being born to a mother with hepatitis C

In rare cases, you could get hepatitis C by

  • getting a tattoo or body piercing with unsterilized, dirty tools

You can NOT get hepatitis C by

  • shaking hands with an infected person
  • hugging an infected person
  • kissing an infected person
  • sitting next to an infected person

 

Could I get hepatitis C from a blood transfusion?

If you had a blood transfusion or organ transplant before 1992, you might have hepatitis C.

Before 1992, doctors could not check blood for hepatitis C, and some people received infected blood. If you had a blood transfusion or organ transplant before 1992, ask a doctor to test you for hepatitis C. (See "What are the tests for hepatitis C?")

Illustration of a Doctor talking to a patient.

A doctor can test you for hepatitis C.

 

What are the symptoms?

Many people with hepatitis C don't have symptoms.

However, some people with hepatitis C feel like they have the flu.

Illustration of a man in bed.

So, you might

  • feel tired
  • feel sick to your stomach
  • have a fever
  • not want to eat
  • have stomach pain
  • have diarrhea

Some people have

  • dark yellow urine
  • light-colored stools
  • yellowish eyes and skin

If you have symptoms or think you might have hepatitis C, go to a doctor.

 

What are the tests for hepatitis C?

Doctor taking a blood sample from a woman's arm.

 

The doctor will take some blood to check for hepatitis C.

To check for hepatitis C, the doctor will test your blood.

These tests show if you have hepatitis C and how serious it is.

The doctor may also do a liver biopsy.

A biopsy (BYE-op-see) is a simple test. The doctor removes a tiny piece of your liver through a needle. The doctor checks the piece of liver for signs of hepatitis C and liver damage.

 

How is hepatitis C treated?

Health care provider, wearing gloves, drawing medicine into a syringe.

Hepatitis C is treated through shots of medicine.

Hepatitis C is treated with a drug called peginterferon, usually in combination with the drug ribavirin.

You may need surgery if you have hepatitis C for many years. Over time, hepatitis C can cause your liver to stop working. If that happens, you will need a new liver. The surgery is called a liver transplant. It involves taking out the old, damaged liver and putting in a new, healthy one from a donor.

 

How can I protect myself?

You can protect yourself and others from hepatitis C.

Man taking a syringe out of a bag.

 

If you inject drugs, use your own needles.

  • Don't share drug needles with anyone.
  • Wear gloves if you have to touch anyone's blood.
  • If you have several sex partners, use a condom during sex.
  • Don't use an infected person's toothbrush, razor, or anything else that could have blood on it.
  • If you get a tattoo or body piercing, make sure it is done with clean tools.
  • If you have hepatitis C, don't give your blood or plasma. The person who receives it could become infected with the virus.

 

For More Information

You can also get information about hepatitis C from these groups:

American Liver Foundation (ALF)
75 Maiden Lane, Suite 603
New York, NY 10038–4810
Phone: 1–800–GO–LIVER (465–4837),
1–888–4HEP–USA (443–7872),
or 212–668–1000
Fax: 212–483–8179
Email: info@liverfoundation.org
Internet: www.liverfoundation.org

Hepatitis Foundation International (HFI)
504 Blick Drive
Silver Spring, MD 20904–2901
Phone: 1–800–891–0707 or 301–622–4200
Fax: 301–622–4702
Email: hfi@comcast.net
Internet: www.hepfi.org

There are other types of hepatitis. The National Digestive Diseases Information Clearinghouse also has booklets about hepatitis A and hepatitis B:

You can get a free copy of each of these booklets by calling 1–800–891–5389 or by writing to

NDDIC
2 Information Way
Bethesda , MD 20892–3570

Hepatitis information for health professionals is also available.

Image of the Hepatitis A and B booklets.

 

Acknowledgments

The individuals listed here provided editorial guidance or facilitated field testing for this publication. The National Digestive Diseases Information Clearinghouse would like to thank them for their contribution.

Bruce Bacon, M.D.
Chair, Education Committee
American Liver Foundation
New York, NY

Luby Garza-Abijaoude, M.S., R.D., L.D.
Texas Department of Health
Austin, TX

Thelma Thiel, R.N., B.A.
Hepatitis Foundation International
Silver Spring, MD

 

National Digestive Diseases Information Clearinghouse

2 Information Way
Bethesda, MD 20892–3570
Email: nddic@info.niddk.nih.gov

The National Digestive Diseases Information Clearinghouse (NDDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services. Established in 1980, the Clearinghouse provides information about digestive diseases to people with digestive disorders and to their families, health care professionals, and the public. The NDDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about digestive diseases.

Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.

This publication is not copyrighted. The Clearinghouse encourages users of this publication to duplicate and distribute as many copies as desired.

NIH Publication No. 04–4229
May 2004

 

 
 
 
Google
Web www.iconocast.com
 
 
Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; Nedws9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

 © 2002-2006

Keywords:

Contact Iconocast